MEITAV INVESTMENT HOUSE LTD - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 35 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
MEITAV INVESTMENT HOUSE LTD ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2023$493,551
+54.8%
244,332
-0.1%
0.01%
+80.0%
Q4 2022$318,828
+24.5%
244,482
+0.1%
0.01%0.0%
Q3 2022$256,000
-3.0%
244,3320.0%0.01%0.0%
Q2 2022$264,000
+2.7%
244,3320.0%0.01%
+25.0%
Q1 2022$257,000
-20.9%
244,3320.0%0.00%
-20.0%
Q3 2021$325,000
-65.2%
244,332
-50.0%
0.01%
-58.3%
Q2 2021$934,000488,6640.01%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Spire Wealth Management 148,800$158,0000.00%
MEITAV INVESTMENT HOUSE LTD 244,332$257,0000.00%
Phoenix Holdings Ltd. 244,113$259,0000.00%
IHT Wealth Management, LLC 24,000$25,0000.00%
Psagot Value Holdings Ltd. / (Israel) 6,000$6,0000.00%
Virtu Financial LLC 15,199$16,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 41,574$44,0000.00%
Smith Salley Wealth Management 12,048$13,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 28,790$31,0000.00%
BANK OF AMERICA CORP /DE/ 5,153$5,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders